Form 4: Entera Bio Director Receives Stock and Options in Lieu of Cash Fees
SEC Form 4
Entera Bio director Gerald M. Lieberman received shares and stock options as compensation for board service in the fourth quarter of 2024.
Summary
- Director Gerald M. Lieberman received 10,717 ordinary shares of Entera Bio as compensation for his board service in the fourth quarter of 2024.
- These shares were awarded in lieu of cash fees.
- Mr. Lieberman also received 28,509 stock options with an exercise price of $2.28 per share.
- The options vest quarterly over a one-year period starting January 1, 2025, and expire on January 15, 2035.
- Mr. Lieberman also has indirect ownership of 24,800 ordinary shares held in trust for his grandchildren, with his spouse as trustee.
Sentiment
Score: 7
Explanation: The document reflects standard compensation practices and does not indicate any significant positive or negative events. It is a routine filing.
Positives
- The award of shares and options aligns director compensation with company performance.
- The vesting schedule of the options encourages long-term commitment from the director.
Future Outlook
The stock options vest over a one-year period, suggesting continued engagement from the director.
Management Comments
- The Board of Directors awarded shares to the Reporting Person in lieu of cash fees for services rendered as a director for the fourth quarter of 2024.
- The options represent the Board's annual grant of options to directors of the Company.
Industry Context
It is common practice for companies to compensate directors with a mix of cash, stock, and options to align their interests with shareholders.
Comparison to Industry Standards
- Director compensation packages often include a mix of cash, equity, and options, similar to the package awarded to Mr. Lieberman.
- The vesting schedule of the options is typical for director grants, encouraging long-term alignment with the company's success.
- The use of trusts for indirect ownership is a common practice for estate planning and asset management.
Stakeholder Impact
- The share and option awards dilute existing shareholders slightly.
- The compensation package aligns the director's interests with the long-term success of the company.
Key Dates
| Date | Description |
|---|---|
| 01/15/2025 | Date of the transaction where shares and options were awarded. |
| 01/15/2035 | Expiration date of the stock options. |
| 01/17/2025 | Date the Form 4 was signed. |
Keywords
Entera Bio, Director Compensation, Stock Options, Share Award, Beneficial Ownership, Form 4, Gerald M. Lieberman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.